AMBRA1 and myopathy: Our data indicate that ablation of Ambra1 leads to a severe myopathy with structural and functional defects of skeletal muscles, characterized by a marked reduction of myofiber density, abnormal orientation and decreased alignment of myofibers, disorganization of sarcomeres, alterations of the tubulo-reticular network and abnormal mitochondria morphology.